CA-VELODYNE-LIDAR
3.1.2019 14:02:11 CET | Business Wire | Press release
Velodyne Lidar, Inc. will introduce and demonstrate its breakthrough new lidar sensor technology at CES 2019 in the Las Vegas Convention Center North Hall, booth #9010. Velodyne will present product demonstrations showing how lidar is advancing vehicle autonomy, safety, and advanced driver assistance systems (ADAS). The in-booth press conference will announce exciting collaborations and strategic partnerships, never-before-seen products, and customer achievements on Wednesday, January 9, at 11:00 a.m. PST.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190103005186/en/
Velodyne will showcase a wide array of products that fully meet all of the auto industry’s lidar needs, including new products to address directional and short-range sensing with trailblazing technology and performance. Velodyne will also introduce complete lidar-based safety solutions that incorporate Velodyne hardware and software. For more details, please see the Velodyne CES new product release on Tuesday, January 8, at 9:00 a.m. PST.
“The new products we are unveiling at CES advance Velodyne’s leadership position in providing the smartest, most powerful lidar solutions for autonomy and driver assistance,” said Anand Gopalan, Ph.D., Chief Technology Officer (CTO) at Velodyne Lidar. “Delivering integrated hardware and software safety solutions is extremely valuable to automakers with the technologies seamlessly working together to provide breakthrough advanced driver assistance systems.”
At CES, live demonstrations of Velodyne’s lidar sensors will show their industry-leading combination of long range, high resolution, and wide field of view. Visitors to the Velodyne booth can experience a lidar point cloud via augmented reality. Velodyne partners also will lead in-booth presentations, unveil new technologies, and demonstrate lidar’s use in autonomy, marine, agriculture, and emerging industries.
Velodyne demonstrations at CES will include:
Velodyne Alpha Puck™. The culmination of ten years of lidar development and learning from millions of road miles, the Alpha Puck is a sensor specifically made for autonomous driving and advanced vehicle safety at highway speeds. Perfect for Level 4-5 autonomy, the sensor produces an image best described as “stunning,” with the highest resolution data set in the world. It boasts the longest range for highway driving and maximum safety.
Velodyne Velarray™. The Velarray’s best-in-class range, resolution, and field of view facilitate robust object detection, allowing for longer braking distance and increased safety. Designed for seamless vehicle integration, this compact sensor generates a richly-detailed directional image, day or night. It can be concealed within roof lines, in bumpers, and - as demonstrated at CES - behind windshields.
The Velodyne booth will also feature Velodyne’s Augmented Reality demonstration that allows people to experience how autonomous vehicles see the world.
“At CES, people can come to the Velodyne booth to experience how our intelligent lidar sensors are enabling autonomous vehicles on the road today,” said Mike Jellen, president and chief commercial officer of Velodyne Lidar. “They can see how Velodyne’s rich computer perception data helps determine the safest way to navigate and direct a self-driving vehicle. Visitors to our booth can also learn how Velodyne’s versatile lidar sensors are utilized in a myriad of trailblazing applications in addition to self-driving cars and driver assistance, including unmanned aerial vehicles, mapping, industrial safety, robotics, security, and more.”
Cutting-Edge Customer and Partner Solutions
Velodyne will present products and presentations from its network of customers and partners that are using lidar technology in a range of innovative solutions. These partners include Accur8vision, AGC, Apex.AI, AutonomouStuff, DeepMap, Local Motors, MechaSpin, and Paracosm.
Accur8vision . Equipped with Velodyne lidar, Accur8vision provides an innovative approach to the security sector. Accur8vision is a volumetric detection system that protects an entire area needing to be secured, compared to perimetric detection which only guards the boundary. With Accur8vision and Velodyne lidar sensors, any intruder who enters the guarded area will never go undetected.
AGC. A world-leading supplier of flat, automotive, and display glass, as well as chemicals and other high-tech materials and components, AGC will showcase windshield technology from its WIDEYE task force. Wideye™ is focused on autonomous vehicles and solid-state lidar integration solutions. Combined with the Velarray™ sensor for an interactive demo in Velodyne’s booth, WIDEYE’s infrared transparent automotive-grade glass provides an ADAS and autonomous solution featuring both seamless design and safer perception.
Apex.AI . Apex.AI builds reliable, safe, and certified software for autonomous vehicles and other autonomous mobility systems. Apex.OS is an SDK compatible ROS 2 (Robot Operating System). It provides a production-grade, safety-certified real-time framework for developing safe and secure autonomous vehicle applications. Apex.Autonomy provides functional building blocks for autonomous vehicles on top of Apex.OS, such as libraries for 3D lidar perception including integration of Velodyne lidars.
AutonomouStuff . AutonomouStuff provides the best R&D platforms, products, software, and engineering services to aid in the advancement of robotics and autonomy. The company has provided solutions for automated driving to thousands of customers worldwide. In order to continue to rise up, companies must surround themselves with the best. This industry is no different. That is why AutonomouStuff chooses to surround itself with a market leader like Velodyne.
DeepMap . HD mapping is a crucial piece of the autonomous vehicle stack that needs to be robust, reliable, and highly scalable. DeepMap provides state-of-the-art mapping and localization to autonomous vehicles as a service. DeepMap helps its customers expedite their autonomous vehicle technology development in a safe and scalable way. Velodyne’s lidar is widely used by DeepMap and its customers for autonomous driving as well as mapping and localization.
Local Motors by LMI . Local Motors will show the world’s first co-created, electric, and self-driving shuttle, Olli. On display will be a current R&D prototype made of a nearly 90 percent 3D-Printed Olli and integrates a range of Velodyne sensors. Local Motors partnered with Velodyne to showcase how Velodyne sensors allow Olli to not only see in 360 degrees, but also ensures coverage of multiple overlapping areas at greater distance with more reliability.
MechaSpin . An industry-leading lidar sensor integrator, MechaSpin will showcase how it has utilized Velodyne’s lidar technology to develop an ecosystem of capabilities to provide solutions in the maritime, intermodal, agriculture, and material handling industries. MechaSpin’s proprietary MSx Processing Engine enables rapid adoption and integration of lidar sensor technology for custom applications.
Paracosm . Paracosm, a division of Occipital, develops PX-80, a handheld 3D mapping device that captures large-scale indoor and outdoor spaces in minutes using Velodyne’s Puck™ sensor. Its CES presentation will highlight exciting, real-world customer use cases from scanning aircraft hangars to the Amazon rainforest for a virtual reality film.
For more information on Velodyne and to download news releases, photos, and videos, please visit https://velodynelidar.com/newsroom/ . Media can schedule an executive interview or product demo by contacting Robin Carr at Landis Communications Inc. (415-971-3991; velodyne@landispr.com ).
About Velodyne Lidar
Velodyne provides the smartest, most powerful lidar solutions for autonomy and driver assistance. Founded in 1983 and headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. In 2005, Velodyne’s Founder and CEO, David Hall, invented real-time surround view lidar systems, revolutionizing perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the perfect for L4-L5 autonomy Alpha Puck™ and the directional view Velarray™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190103005186/en/
Contact:
Robin Carr Landis Communications Inc. (415) 971-3991 velodyne@landispr.com www.landispr.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom